203 related articles for article (PubMed ID: 26991092)
1. Locally Produced IL-10 Limits Cutaneous Vaccinia Virus Spread.
Cush SS; Reynoso GV; Kamenyeva O; Bennink JR; Yewdell JW; Hickman HD
PLoS Pathog; 2016 Mar; 12(3):e1005493. PubMed ID: 26991092
[TBL] [Abstract][Full Text] [Related]
2. Skin inflammation in RelB(-/-) mice leads to defective immunity and impaired clearance of vaccinia virus.
Freyschmidt EJ; Mathias CB; MacArthur DH; Laouar A; Narasimhaswamy M; Weih F; Oettgen HC
J Allergy Clin Immunol; 2007 Mar; 119(3):671-9. PubMed ID: 17336617
[TBL] [Abstract][Full Text] [Related]
3. Immunobiology of infection with recombinant vaccinia virus encoding murine IL-2. Mechanisms of rapid viral clearance in immunocompetent mice.
Karupiah G; Woodhams CE; Blanden RV; Ramshaw IA
J Immunol; 1991 Dec; 147(12):4327-32. PubMed ID: 1684375
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-15 mediates potent antiviral responses via an interferon-dependent mechanism.
Foong YY; Jans DA; Rolph MS; Gahan ME; Mahalingam S
Virology; 2009 Oct; 393(2):228-37. PubMed ID: 19729181
[TBL] [Abstract][Full Text] [Related]
5. Impaired immune response to vaccinia virus inoculated at the site of cutaneous allergic inflammation.
Scott JE; ElKhal A; Freyschmidt EJ; MacArthur DH; McDonald D; Howell MD; Leung DY; Laouar A; Manjunath N; Bianchi T; Boes M; Oettgen HC; Geha RS
J Allergy Clin Immunol; 2007 Dec; 120(6):1382-8. PubMed ID: 17889291
[TBL] [Abstract][Full Text] [Related]
6. Anatomically restricted synergistic antiviral activities of innate and adaptive immune cells in the skin.
Hickman HD; Reynoso GV; Ngudiankama BF; Rubin EJ; Magadán JG; Cush SS; Gibbs J; Molon B; Bronte V; Bennink JR; Yewdell JW
Cell Host Microbe; 2013 Feb; 13(2):155-68. PubMed ID: 23414756
[TBL] [Abstract][Full Text] [Related]
7. Cytokine-armed vaccinia virus infects the mesothelioma tumor microenvironment to overcome immune tolerance and mediate tumor resolution.
Jackaman C; Nelson DJ
Cancer Gene Ther; 2010 Jun; 17(6):429-40. PubMed ID: 20150930
[TBL] [Abstract][Full Text] [Related]
8. Preferential replication of vaccinia virus in the ovaries is independent of immune regulation through IL-10 and TGF-β.
Zhao Y; Adams YF; Croft M
Viral Immunol; 2011 Oct; 24(5):387-96. PubMed ID: 21958373
[TBL] [Abstract][Full Text] [Related]
9. Vaccinia virus induces strong immunoregulatory cytokine production in healthy human epidermal keratinocytes: a novel strategy for immune evasion.
Liu L; Xu Z; Fuhlbrigge RC; Peña-Cruz V; Lieberman J; Kupper TS
J Virol; 2005 Jun; 79(12):7363-70. PubMed ID: 15919891
[TBL] [Abstract][Full Text] [Related]
10. Nonreplicating recombinant vaccinia virus expressing CD40 ligand enhances APC capacity to stimulate specific CD4+ and CD8+ T cell responses.
Feder-Mengus C; Schultz-Thater E; Oertli D; Marti WR; Heberer M; Spagnoli GC; Zajac P
Hum Gene Ther; 2005 Mar; 16(3):348-60. PubMed ID: 15812230
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of S100A11 gene expression impairs keratinocyte response against vaccinia virus through downregulation of the IL-10 receptor 2 chain.
Bin L; Howell MD; Kim BE; Hall CF; Streib JE; Leung DY
J Allergy Clin Immunol; 2009 Aug; 124(2):270-7, 277.e1. PubMed ID: 19577285
[TBL] [Abstract][Full Text] [Related]
12. IL-1R Type 1-Deficient Mice Demonstrate an Impaired Host Immune Response against Cutaneous Vaccinia Virus Infection.
Tian T; Jin MQ; Dubin K; King SL; Hoetzenecker W; Murphy GF; Chen CA; Kupper TS; Fuhlbrigge RC
J Immunol; 2017 Jun; 198(11):4341-4351. PubMed ID: 28468973
[TBL] [Abstract][Full Text] [Related]
13. Monocytic myeloid-derived suppressor cells regulate T-cell responses against vaccinia virus.
Fortin C; Yang Y; Huang X
Eur J Immunol; 2017 Jun; 47(6):1022-1031. PubMed ID: 28383204
[TBL] [Abstract][Full Text] [Related]
14. Primary human macrophages serve as vehicles for vaccinia virus replication and dissemination.
Byrd D; Shepherd N; Lan J; Hu N; Amet T; Yang K; Desai M; Yu Q
J Virol; 2014 Jun; 88(12):6819-31. PubMed ID: 24696488
[TBL] [Abstract][Full Text] [Related]
15. The CD8 T cell response to vaccinia virus exhibits site-dependent heterogeneity of functional responses.
Xiao Z; Curtsinger JM; Prlic M; Jameson SC; Mescher MF
Int Immunol; 2007 Jun; 19(6):733-43. PubMed ID: 17545279
[TBL] [Abstract][Full Text] [Related]
16. Type I interferon-dependent CCL4 is induced by a cGAS/STING pathway that bypasses viral inhibition and protects infected tissue, independent of viral burden.
Parekh NJ; Krouse TE; Reider IE; Hobbs RP; Ward BM; Norbury CC
PLoS Pathog; 2019 Oct; 15(10):e1007778. PubMed ID: 31603920
[TBL] [Abstract][Full Text] [Related]
17. Vaccinia virus infection of mature dendritic cells results in activation of virus-specific naïve CD8+ T cells: a potential mechanism for direct presentation.
Yates NL; Alexander-Miller MA
Virology; 2007 Mar; 359(2):349-61. PubMed ID: 17056088
[TBL] [Abstract][Full Text] [Related]
18. IL-12 and IL-18 act in synergy to clear vaccinia virus infection: involvement of innate and adaptive components of the immune system.
Gherardi MM; Ramírez JC; Esteban M
J Gen Virol; 2003 Aug; 84(Pt 8):1961-1972. PubMed ID: 12867626
[TBL] [Abstract][Full Text] [Related]
19. Changes in epidermal Langerhans cells, gamma delta T cells and CD4 T cells after intradermal infection with recombinant vaccinia virus expressing cytokine genes.
Hernando RA; Ruby JC; Halliday GM
Immunol Cell Biol; 1994 Oct; 72(5):383-9. PubMed ID: 7835982
[TBL] [Abstract][Full Text] [Related]
20. Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus.
Howell MD; Gallo RL; Boguniewicz M; Jones JF; Wong C; Streib JE; Leung DY
Immunity; 2006 Mar; 24(3):341-8. PubMed ID: 16546102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]